$GECC

Great Elm Capital Corp. ("GECC") Schedules Third Quarter 2025 Earnings Release and Conference Call

Conference Call Scheduled for Wednesday, November 5, 2025 at 8:30 a.m. ET Conference Call Scheduled for Wednesday, November 5, 2025 at 8:30 a.m. ET ...

Original reporting
GlobeNewswire · Great Elm Capital Corp.
Published Oct 31, 2025, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 1, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Great Elm Capital Corp. ("GECC") Schedules Third Quarter 2025 Earnings Release and Conference Call — source image
Decision brief

The 30-second read

$GECCNeutralMed
01

Why it matters

Earnings announcements often lead to increased trading volume and volatility, especially if results differ from analyst expectations.

02

Market read

The upcoming earnings release is a significant event for traders and investors focusing on GECC and its sector.

03

What to watch

Market conditions, macroeconomic factors, and broader industry trends could overshadow the earnings impact.

Relevance 6/10Timing: High, as the event is scheduled for November 5, 2025.

Background

Great Elm Capital Corp. (GECC) is scheduled to release its Q3 2025 earnings on November 5, 2025, with a conference call at 8:30 a.m. ET.

Company-level read

Ticker impact

$GECCNeutralMedium confidence
Context

The upcoming earnings release is a scheduled event that could influence short-term trading activity.

Expected impact

Moderate increase or decrease in stock price expected, depending on earnings results and guidance.

Evidence & confidence

While scheduled earnings can influence stock prices, the current sentiment is mixed, and the impact depends on actual earnings performance and market reaction.

Market effects

Potential sector-wide volatility if earnings results deviate significantly from expectations.

Limited regional impact, primarily affecting investors and traders in the U.S.

Minimal, as the news pertains to a specific company and sector.

Counterpoint

Earnings results may be in line with expectations, leading to minimal price movement and rendering the event less impactful for trading.

Key entities

  • Great Elm Capital Corp.

    A financial services company providing specialty finance and investment management services.

Related articles

$GECCMed

Great Elm Capital Corp. Announces SECOND Quarter 2026 Financial Results

Great Elm Capital Corp. (GECC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Great Elm Capital Corp. Announces SECOND Quarter 2026 Financial Results Company to Host Conference Call and Webcast at 8:30 AM ET on August 6, 2026 GECC’s Investment Adviser Waives Incentive Fees Totaling $0.9 million or $0.06 Per Share for the Quarter Ended June 30,

$SKYDMed

Skydance Could Outscale Netflix, Disney, Says JPMorgan In Upgrade

JPMorgan upgraded Skydance (SKYD) to 'Neutral' from 'Underweight,' citing its Warner Bros. Discovery acquisition, which creates a media company larger than Netflix (NFLX) and Disney (DIS). The firm lowered its price target to $9, implying 15% upside. Skydance, now owning Paramount, Warner Bros., and streaming services, expects $70B revenue annually and $6B in synergies. Analysts remain cautious, with only 4 of 23 rating it 'Buy' or 'Strong Buy'.

$SKYDMed

SKYD Stock Gets JPMorgan Upgrade: Analyst Sees Skydance Gaining Ground On Netflix, Disney With Warner Bros. Deal

JPMorgan upgraded Skydance (SKYD) to 'Neutral' from 'Underweight', lowering its price target to $9. The firm cited Skydance's Warner Bros. Discovery acquisition, which creates a media company with nearly $70B in annual revenue. SKYD stock was little changed in midday trade. Wall Street remains cautious, with most analysts recommending 'Hold' or 'Sell'.

$AAPLMed

Apple's $2,000 Foldable iPhone Duo Hits Stores Amid Supply Crunch

Apple Inc. (AAPL) launched its first foldable iPhone, priced at around $2,000, with high demand leading to supply shortages. Preorders were capped at two per buyer, and delivery dates quickly extended to January. IDC projects Apple to capture 44% of the foldable market's value by 2026. Early reviews praised the device's design but noted some limitations, such as the lack of a telephoto camera.

$TNGXMedAI 8/10

Wedbush raises Tango Therapeutics stock price target on trial data

Wedbush raised Tango Therapeutics' (TNGX) price target to $45 from $39, citing positive trial data for vopimetostat in combination with RayzeBio's inhibitors. The stock has surged 271% over the past year, trading at $24.21 with a $4.06B market cap. Analysts see potential upside of 61% to their consensus target. Other analysts have also raised targets, with H.C. Wainwright at $68 and Stifel at $55.